Summary
Updated Aug 31, 2026
Amy W. Schulman is Director of ALNYLAM PHARMACEUTICALS, INC. (ALNY). 6 SEC Form 4 filings on record going back to 2025, most recently on 22 May 2026. Most recent open-market trade: sold $7K of ELV on 23 March 2026. Lifetime open-market sales: $7K.
Recent Transactions
6Every recent SEC Form 4 transaction Amy W. Schulman has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Amy W. Schulman go back to 2025: 6 primary Form 4 filings, an average of 3.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Amy W. Schulman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Yvonne Greenstreet - $20.98M of ALNY open-market activity in the last 12 months
- Kevin Joseph Fitzgerald - $9.34M of ALNY open-market activity in the last 12 months
- Colleen F. Reitan - $8.42M of ALNY open-market activity in the last 12 months
- Pushkal Garg - $7.58M of ALNY open-market activity in the last 12 months
- Jeffrey V. Poulton - $3.94M of ALNY open-market activity in the last 12 months
- Tolga Tanguler - $2.51M of ALNY open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Amy W. Schulman?
Amy W. Schulman is a corporate insider, tracked as Director of ALNYLAM PHARMACEUTICALS, INC. (ALNY). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Amy W. Schulman last file a Form 4?
The most recent primary Form 4 on record is dated 22 May 2026, one of 6 filings going back to 2025.
Has Amy W. Schulman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($7K) across all tracked filings.
Where can I see all of Amy W. Schulman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Amy W. Schulman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial